Inhalational anthrax and bioterrorism

Current Opinion in Pulmonary Medicine

Volumn 9, Issue 3, 2003, Pages 221-226

  Quintiliani Jr , Richard ^b   Quintiliani, Richard ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS DARTMOUTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTHRAX VACCINE; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFAZOLIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; PENICILLIN DERIVATIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE DERIVATIVE; VANCOMYCIN;

ANTHRAX; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; BACILLUS ANTHRACIS; BIOLOGICAL WARFARE; CLINICAL FEATURE; DISEASE TRANSMISSION; HUMAN; INHALATION; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; RESPIRATORY TRACT INFECTION; REVIEW; SEROLOGY; TERRORISM; THORAX RADIOGRAPHY;

ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; BIOTERRORISM; CONNECTICUT; DRUG THERAPY, COMBINATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; INCIDENCE; MALE; PROGNOSIS; RADIOGRAPHY, THORACIC; RESPIRATORY TRACT INFECTIONS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS;

EID: 0037403867     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200305000-00011     Document Type: Review

References (12)

1. Suffin SC, Carnes WH, Kaufmann AF: Inhalation anthrax in a home craftsman. Hum Pathol 1978, 9:594-597.
2. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH: Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A 1993, 90:2291-2294. This report, based on the epidemic of inhalational anthrax in Sverdlovsk, Russia in 1979, describes the largest series of human inhalational anthrax that has undergone postmortem analysis. The authors' findings show that B. anthracis bacteria disseminate widely, especially to the central nervous system and the gastrointestinal tract.
3. Bartlett JG, Inglesby TV Jr, Boric L: Management of anthrax. Clin Infect Dis 2002, 35:851-858.
4. Quinn CP, Semenova VA, Elie CM, et al.: Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen. Emerg Infect Dis 2002, 8:1103-1110.
5. Guidi-Rontani C, Weber-Levy M, Labruyere E, Mock M: Germination of Bacillus anthracis spores within alveolar macrophages. Mol Microbiol 1999, 31:9-17.
6. Guidi-Rontani C, Pereira Y, Ruffie S, et al.: Identification and characterization of a germination operon on the virulence plasmid pXO1 of Bacillus anthracis. Mol Microbiol 1999, 33:407-414.
7. Henderson DW, Peacock S, Belton F: Observations on the prophylaxis of experimental pulmonary anthrax in the monkey. J Hyg 1956, 54:28-36.
8. Inglesby TV, Henderson DA, Bartlett JG, et al.: Anthrax as a biologic weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 1999, 281:1735-1745.
9. Jernigan JA, Stephens DS, Ashford DA, et al.: Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944. An excellent and useful review that provides a clinical summary of the first 10 cases of bioterrorism-related inhalational anthrax reported in the United States in 2001.
10. Quintiliani R Jr, Quintiliani R: Fatal case of inhalational anthrax mimicking intraabdominal sepsis. Conn Med 2002, 66:261-267. A case of inhalational anthrax that presented as intraabdominal sepsis. This case highlights the fact that many patients with inhalational anthrax present with gastrointestinal symptoms.
11. Stepanov AV, Marinin LI, Pomerantsev AP, Staritsin NA: Development of novel vaccines against anthrax in man. J Biotechnol 1996, 44:155-160.
12. Inglesby TV, O'Toole T, Henderson DA, et al.: Anthrax as a biologic weapon, 2002: updated recommendations for management. JAMA 2002, 287:2236-2252. This comprehensive review includes consensus-based recommendations follow-ing a B. anthracis attack against a civilian population. It includes specific recommendations for vaccination, therapy, postexposure prophylaxis and decontamination.